Leprosy is an infectious disease that affects the skin and nervous system. Patients treated with Dapsone may exhibit Dapsone Hypersensitivity Syndrome (DHS) and potentially cause death 9.9% of the time. A Study confirmed that HLA-B* 13:01 is associated with DHS and carriers of at least one allele are 233.3 times more at risk.